Intestinal alterations and mild glucose homeostasis impairments in the offspring born to overweight rats
Molecular and Cellular Endocrinology · 2024
DOI: 10.1016/j.mce.2024.112201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2024. Verfasst von Florencia Heinecke und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pharmacological and Botanical Studies (CEFYBO-CONICET-UBA), School of Medicine, University of Buenos Aires, Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Overweight, Gastric Inhibitory Polypeptide. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Consejo Nacional de Investigaciones Científicas y Técnicas, Agencia Nacional De Promoción Científica Y Tecnológica.
Abstract (Originalsprache)
The gut plays a crucial role in metabolism by regulating the passage of nutrients, water and microbial-derived substances to the portal circulation. Additionally, it produces incretins, such as glucose-insulinotropic releasing peptide (GIP) and glucagon-like derived peptide 1 (GLP1, encoded by gcg gene) in response to nutrient uptake. We aimed to investigate whether offspring from overweight rats develop anomalies in the barrier function and incretin transcription. We observed pro-inflammatory related changes along with a reduction in Claudin-3 levels resulting in increased gut-permeability in fetuses and offspring from overweight rats. Importantly, we found decreased gip mRNA levels in both fetuses and offspring from overweight rats. Differently, gcg mRNA levels were upregulated in fetuses, downregulated in female offspring and unchanged in male offspring from overweight rats. When cultured with high glucose, intestinal explants showed an increase in gip and gcg mRNA levels in control offspring. In contrast, offspring from overweight rats did not exhibit any response in gip mRNA levels. Additionally, while females showed no response, male offspring from overweight rats did exhibit an upregulation in gcg mRNA levels. Furthermore, female and male offspring from overweight rats showed sex-dependent anomalies when orally challenged with a glucose overload, returning to baseline glucose levels after 120 min. These results open new research questions about the role of the adverse maternal metabolic condition in the programming of impairments in glucose homeostasis, enteroendocrine function and gut barrier function in the offspring from overweight mothers and highlight the importance of a perinatal maternal healthy metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Pharmacological and Botanical Studies (CEFYBO-CONICET-UBA), School of Medicine, University of Buenos Aires, Buenos Aires, Argentina.
- Centre for Pharmacological and Botanical Studies (CEFYBO-CONICET-UBA), School of Medicine, University of Buenos Aires, Buenos Aires, Argentina. Electronic address: vernica73@gmail.com.
Förderung
- Consejo Nacional de Investigaciones Científicas y Técnicas
- Agencia Nacional De Promoción Científica Y Tecnológica
Zitieren
APA
Heinecke, F., Fornes, D., Capobianco, E., Flores Quiroga, J. P., Labiano, M., Faletti, A. G., Jawerbaum, A., & White, V. (2024). Intestinal alterations and mild glucose homeostasis impairments in the offspring born to overweight rats. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2024.112201
Vancouver
Heinecke F, Fornes D, Capobianco E, Flores Quiroga JP, Labiano M, Faletti AG, et al. Intestinal alterations and mild glucose homeostasis impairments in the offspring born to overweight rats. Molecular and Cellular Endocrinology. 2024. doi:10.1016/j.mce.2024.112201
BibTeX
@article{Heinecke2024,
author = {Heinecke, Florencia and Fornes, Daiana and Capobianco, Evangelina and Flores Quiroga, Jeremias Pablo and Labiano, Marina and Faletti, Alicia G and Jawerbaum, Alicia and White, Verónica},
title = {Intestinal alterations and mild glucose homeostasis impairments in the offspring born to overweight rats},
journal = {Molecular and Cellular Endocrinology},
year = {2024},
doi = {10.1016/j.mce.2024.112201}
}
EUVIMED